Emergency use authorization of the Mpox vaccine by NAFDAC: A crucial step in Nigeria’s public health response
![](https://nafdac.gov.ng/wp-content/uploads/2024/08/Mpox-cover-latest-1024x300.png)
The 2022 Monkeypox (Mpox) outbreak, initially detected in the United Kingdom, posed a significant global health challenge. The World Health Organization’s declaration of a Public Health Emergency of International Concern underscored the urgency of the situation. In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) took proactive measures to ensure the […]